“These new data are encouraging and reinforce our belief that the Moderna COVID-19 Vaccine should remain protective against newly detected variants,” Stéphane Bancel, Moderna’s chief executive officer, said in a statement. “These findings highlight the importance of continuing to vaccinate populations with an effective primary series vaccine.”
The company also said it is developing a booster candidate: a 50–50 mix of its currently authorized COVID-19 vaccine and another messenger RNA vaccine it has developed.
The delta variant is the fast-moving form of the coronavirus that is now found in 96 countries, including the United States.
Comments are closed.